ACS Chemical Biology · 2022 · 20 citations · 24 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructural BiologyDrug-target Interaction MappingImmune Checkpoint InhibitorsLigand BindingProtein DimerizationProtein StructureBiophysical AssaysBiophysical CharacterizationFragment-based Ligand DesignNuclear Magnetic Resonance StudiesOligomerizationPd-l1 BlockadeProtein TargetsTarget Protein Structure
hot spot mapping and nuclear magnetic resonance (NMR)-based characterization. We found that the conformational elasticity of the PD-L1 surface strongly influences the formation of hot spots. We deconstructed several generations of known inhibitors into fragments and examined their binding properties using differential scanning fluorimetry (DSF) and protein-based nuclear magnetic resonance (NMR). These biophysical analyses showed that not all fragments bind to the PD-L1 ectodomain despite having the biphenyl scaffold. Although most of the binding fragments induced PD-L1 oligomerization, two compounds, TAH35 and TAH36, retain the monomeric state of proteins upon binding. Additionally, the presence of the entire ectodomain did not affect the binding of the hit compounds and dimerization of PD-L1. The data demonstrated here provide important information on the PD-L1 druggability and the structure-activity relationship of the biphenyl core moiety and therefore may aid in the design of novel inhibitors and focused fragment libraries for PD-L1.
24
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
Krzysztof M. Żak, Radosław Kitel, Sara Przetocka et al. · Structure · 2015 · 526 citations · Full text
Katarzyna Guzik, Krzysztof M. Żak, P. Grudnik et al. · Journal of Medicinal Chemistry · 2017 · 360 citations · Full text